KimberlyA.SkeldingMD(She/Her)
Cardiology • Jersey City, NJInterventional Cardiology, Preventive Cardiology
Structural and Interventional Cardiologist, researcher, educator and administrator.
Dr. Skelding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
377 Jersey Avenue
450
Jersey City, NJ 07302Phone+1 201-915-2525Fax+1 201-915-2945- Is this information wrong?
Summary
- Dr. Kimberly Skelding is the Division Chief for Cardiovascular Services, Chief of Cardiology at RWJBarnabas Health in Jersey City, NJ. An interventional cardiologist who specializes in the treatment of valvular and coronary heart disease. Lectures nationally and internationally. Published over 100 articles in her field. A nationally known thought leader, researcher and clinician.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Interventional Cardiology, 2004 - 2005
Beaumont Health (Royal Oak)Fellowship, Cardiovascular Disease, 1999 - 2002
Geisinger Health System (Danville)Residency, Internal Medicine, 1996 - 1999
Northwestern University The Feinberg School of MedicineClass of 1996
Certifications & Licensure
NJ State Medical License 2023 - 2025
WA State Medical License 2020 - 2024
VA State Medical License 2019 - 2024
PA State Medical License 1997 - 2022
GA State Medical License 2020 - 2021
AL State Medical License 2017 - 2020
MI State Medical License 1998 - 2005- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- Join now to see all
Awards, Honors, & Recognition
- Fellow SCAI
- Fellow American Heart Association
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Spontaneous Coronary Artery Dissection (SCAD) from an Interventionalist Perspective.Nichole Brunton, Patricia J M Best, Kimberly A Skelding, Emily E Cendrowski> ;Current Cardiology Reports. 2024 Mar 1
- Invited Commentary: Impact of New eGFR Equations on Risk Assessment in Patients Undergoing Transcatheter Aortic Valve Replacement.Kimberly A Skelding, Kraev, A., Alexander S Kraev> ;Cardiovascular Revascularization Medicine. 2023 Apr 1
- Conversations in cardiology: Late career transitions-Retool, retire, refocus.Morton J Kern, Bob Applegate, John Bittl, Peter Block, Sam Butman, Gregory Dehmer, Kirk N Garratt, Tim Henry, John Hirshfeld, David R Holmes Jr, Aaron Kaplan, Spencer ...> ;Catheterization and Cardiovascular Interventions. 2022 Jun 1
- Join now to see all
Press Mentions
Dr. Skelding, Dr. Lynch, & Dr. Kamal - Top 3 Physicians for Acute Myocardial Infarction Based on Experience and Patient Volume in Tuscaloosa County, AlabamaJuly 13th, 2022
Hospitals, Physicians Fight for Women's Equity in Healthcare Research, DeliveryOctober 13th, 2014
Professional Memberships
- Fellow
- Fellow
- Society for Cardiovascular Angiography and InterventionFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
